Skip to content
MarketScale
‹ Back to IndustriesHealthcare

A Category Deep Dive on Dialysis

Dialysis is a necessary procedure that allows nearly 500,000 patientsin the United States with kidney failure the opportunity to live normal, productive lives. The treatment removes waste, salt, and extra water when the native kidneys are no longer able. Though there are several types of dialysis, the most common is Hemodialysis, in which blood is removed from the…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Dialysis is a necessary procedure that allows nearly 500,000 patientsin the United States with kidney failure the opportunity to live normal, productive lives. The treatment removes waste, salt, and extra water when the native kidneys are no longer able. Though there are several types of dialysis, the most common is Hemodialysis, in which blood is removed from the body, run through a dialyzer, cleaned, and replaced into the body. Dialysis takes three hours to complete and is offered by health systems as inpatient and outpatient treatments.

The federal government pays 80% of all dialysis costs for most patients via Medicare. In fact, the dialysis industry experienced large significant in 1972 when procedures became covered through this program. The industry is run on a for-profit basis, with the market being dominated by two large publicly traded companies known as DaVita and Fresenius. Smaller communities and rural healthcare organizations are more likely to turn to the many local and regional dialysis service providers. Additionally, hospitals or treatment centers must assess the option of operating their own dialysis center for maximum convenience to their patients.

Technology is available to help determine every cost within every purchased services expense category of a health system, revealing massive savings potential in important areas, including dialysis. Here are several factors that healthcare providers should know about dialysis when considering opportunities for savings.

  • The Need for Dialysis is Going Up: The number of patients requiring End Stage Renal Dialysis treatment is increasing each year, with mortality rates depending on the treatment. ESRD, or renal failure, is the fastest-growing cause of hospitalizations, and the fifth leading reason for readmissions.
  • Dialysis Is a Competitive Business. With multiple options usually available for health systems, it’s essential to ensure your organization has evaluated them all recently. Joint ventures between hospitals or health systems and dialysis providers are common. A patient’s choice in healthcare provider and dialysis company are critical factors in driving usage of centers.
  • Savings Opportunities Exist in the Cost of Smaller Purchased Services: Ongoing dialysis treatments can be categorized into purchased services, which is any service contracted and performed by a third party as opposed to the in-house staff at the hospital. Purchased services can account for up to 45% of an average U.S. hospital’s non-labor expenses. However, most health systems continuously tackle savings within the larger categories only, including food, EVS, and blood, ignoring the smaller purchased services categories.
  • Categorize the Entire Spend in a System: Without categorizing their entire purchased services spend and prioritizing opportunities, health systems are missing out on addressing smaller categories—including dialysis—that still have large savings opportunities. Why? Without technology, many systems are not able to categorize their entire organization’s spend and prioritize these kinds of opportunities.

Effective Category Monitoring Helps Health Systems Thrive

By prioritizing opportunities and categorizing purchased service costs, health systems will no longer fail to acknowledge dialysis and other smaller categories. Hospitals and healthcare systems using purchased services expense management technology can identify areas of financial improvement in smaller categories like dialysis by utilizing software that not only identifies but breaks down purchased services and reveals a deeper understanding of the overall costs.

Many Americans require dialysis treatment; however, it is an often-ignored category within purchases services that has potential for great savings. At Valify, we offer a breakthrough technology that uses innovative tools to reveal savings opportunities for each expense, saving hospitals 20-30% per purchased service category, on average.

To discover how our technology platform operates, request a live demo at getvalify.com/demo-valify.

Read more at getvalify.com

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512